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Abstract
Background: The use of neuropsychiatric Patient Centred Outcome Measures (PCOMs) in routine child mental health
and paediatric services is very time consuming and often requires multiple scales being completed as no single
scale covers all areas of psychopathology. The use of a web-based programme can overcome these problems and
contribute to improved use of PCOMs in clinical practice. We aim to develop a web-based scale (using HealthTracker™)
to screen and identify young people with significant neuropsychiatric symptoms to enable early intervention.
Methods: Qualitative development of the Profile of Neuropsychiatric Symptoms (PONS) and quantitative evaluation
of the psychometric properties of the PONS scale (parent version). Parents of 929 from the general population and
147 with neuropsychiatric disorders (5–18 years old) completed the PONS online. In addition, those children with
neuropsychiatric disorders were assessed for the presence of current and lifetime psychiatric disorders using the
Development and Well-Being Assessment (DAWBA).
Results: The PONS scale (parent version) consists of 30 symptom domains rated on a 7-point scale for both frequency
and impairment. We found an intra-class correlation coefficient for single measures was 0.44 (0.42-0.46 95 % CI,
F = 22.84, p≤ 0.0001) and for average measures was 0.96 (0.95-0.96 95 % CI, F = 22.84, p≤ 0.0001). The factor analysis
showed a 4-factor model: Neurodevelopmental Disability; Behavioural and Emotional Dysregulation; Psychoses and
Personality Dysfunction; and Anxiety and Depression. The receiver operating characteristic area for the 4-factors was
0.96 (SE = 0.006; 0.95-0.97 95 % CI).
Conclusions: The PONS scale (parent version) is a web-based PCOM on the HealthTracker™ system that is a rapid,
engaging measure that has excellent reliability and validity. The system allows for automated scoring and immediate
feedback of statistical cut-off points and assists clinicians with diagnostic decision-making and optimises use of
clinician time.
Keywords: Profile Of Neuropsychiatric Symptoms scale, Patient reported outcomes, Patient centred outcome
measures, Internet-based scale, Psychometric properties, HealthTracker™
Background
Epidemiological research has shown that between 12 %
and 14 % of young people have a mental disorder caus-
ing significant functional impairment [1, 2], 5 % have
neurodevelopmental disorders [3]. However, only about
one quarter of them are in contact with specialist mental
health services [4, 5].
Methods for assessing the prevalence and community
burden of psychiatric disorders in children and adoles-
cents have improved dramatically in the past decade [1].
There is a broad range of standardized structured inter-
views and self-report assessments that generate Diagnostic
and Statistical Manual (DSM) Mental Disorder diagnoses
with good reliability and validity [1]. Using neuropsy-
chiatric Patient Centred Outcome Measures (PCOMs) in
routine child mental health and paediatric services is
very time consuming and often requires multiple scales
being completed as no single scale covers all areas of
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psychopathology. Most children and adolescents attending
mental health or neurodisability services have symptoms
of more than one emotional or behavioural developmental
disorder. Currently, there are many disorder-specific
rating scales, but none that are child or parent rated that
include symptoms of neurodevelopmental disorders such
as attention deficit hyperactivity disorder and autism
spectrum disorders alongside symptoms of psychoses,
bipolar disorder, anxiety and depression. The commonly
used measures such as the Child Behaviour Check List
(CBCL) [6], and the Strength and Difficulties Questionnaire
(SDQ) [7] currently do not cover all the above areas ad-
equately. There is an urgent need to develop brief PCOMs
for childhood neuropsychiatric disorders and neurodisabi-
lity, that can be completed in around 10 min, capture fre-
quency and impairment arising from symptoms of multiple,
relevant, co-occurring disorders in a dimensional manner
allowing its use across conditions. It would be useful if the
PCOM could be used longitudinally to capture change.
There is a need to capture domain-specific, dimensional
frequency and impairment ratings, which would uniquely
allow the PCOM to be used across diagnostic categories,
allowing for use in research using the NIH Research
Domain Criteria (RDoC) [8] (http://www.nimh.nih.gov/
research-priorities/rdoc/index.shtml). The RDoC project
intends to develop, for research purposes, new ways of clas-
sifying mental disorders based on behavioral dimensions
and neurobiological measures [8]. RDoC attempts to bring
the power of modern research approaches in genetics,
neuroscience, and behavioral science to the problems of
mental illness, studied independently from the classification
systems by which patients are currently grouped.
PCOMs include the self/proxy assessments of symp-
toms, functional status, or other concerns such as pa-
tient needs and satisfaction with care ([9–15]. The use of
a web-based programme can contribute to improved use
of PCOMs in clinical practice [16]. Technology can en-
hance the lives of most individuals, especially those with
neurodisabilities [17–20], who will benefit through the
use of the HealthTracker™, an existing web-based health-
monitoring platform. HealthTracker™ is an established
platform for online collection and storage of medical
data that allows multi-modal presentation of ques-
tionnaires (including animated scale presentations for
young children) and assists in automatically allocating
questionnaires based on developmental level rather than
chronological age. Online display allows questionnaires
to be presented in a client-friendly manner in many
languages, assisted by audio recordings for those who
have dyslexia and visual impairment [21, 22]. In
addition, being web-based, it allows for more frequent
assessment without clinic visits.
Children and adolescents with intellectual disabilities and
challenging behaviours can make conventional assessment
difficult [23]. For the reasons stated above, more work is
needed to improve PCOMs, especially harnessing techno-
logy, to screen young people and identify early childhood
onset of psychiatric disorders to enable early intervention;
especially in those with neurodisability. The Profile Of
Neuropsychiatric Symptoms (PONS) was developed to
screen and capture information on specific symptom do-
mains that are commonly seen in neurodevelopmental,
neuropsychiatric and emotional and behavioural disorders
in children and young people, developed in a manner to
capture change in symptom frequency and impairment
across time, using current FDA protocols for development
of PCOMs and the NIH RDoC agenda. It was developed
with a view to capture symptoms of developmental disor-
ders such as ADHD, ASD, OCD, motor coordination dis-
order; disruptive disorders such as ODD and Conduct
Disorder; Psychoses, Bipolar Disorder and Emerging Per-
sonality Disorder; and Anxiety and Depressive Disorders.
Currently no existing single scale is able to capture all
these symptoms in a scale that can be completed in
around 10–12 min, which can also be used to track
change between clinic visits.
The objective of this project was to develop the web-
based PONS. For this purpose, we followed the FDA re-
commendations for patient reported outcome measures
(currently called PCOMs) [24, 25] and principles used in
the Patient Reported Outcomes Measurement Informa-
tion System (PROMIS). PROMIS is an NIH-funded initia-
tive to develop instruments to be used across chronic
conditions as a system of highly reliable, precise measures
of patient–reported health status for physical, mental, and
social well–being (www.nihpromis.org).
The Profile of Neuropsychiatric Symptoms (PONS)
consists of three child versions - for young children (5–7
years old), children (8–11 years old) and adolescents
(12–18 years old); a parent or carer version, a teacher
version, and a clinician version. This paper will report
on the parent version of the PONS and its qualitative
development, and the quantitative evaluation of its psy-
chometric properties in child and adolescent controls
from the general population and a group with neuro-
psychiatric disorders.
Methods
Phase 1: qualitative development of the PONS scale
Institutional Review Board approval was obtained from
the Guy’s and St Thomas’s Hospitals NHS Trust before
subject enrolment. Online informed consent was obtained
from all control participants (i.e., child, adolescent, parent)
before study instruments were administered. In the clinic
sample, the PONS was completed as part of routine cli-
nical care and we had consent for anonymized use of all
clinical data.
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The uniqueness of this instrument is that each domain
describes what a child with a specific symptom domain
would look like, rather than focusing on individual
items, for example, hyperactivity is described as ‘a child
who is unable to sit still, is constantly on the go, fidgets,
is restless.’ This allows the parent and child to under-
stand what constitutes hyperactivity rather than having
separate symptom items to capture the domain of hyper-
activity. Initial symptom domains of the PONS scale was
based on a detailed literature review, followed by a con-
sensus of child and adolescent psychiatrists and neuro-
developmental paediatricians with extensive experience
in neuropsychiatric disorders of young people, and fami-
lies with children with neuropsychiatric problems. The
initial draft of the PONS scale was discussed with a
panel of experts of child psychiatrists, paediatricians,
neurodevelopmental paediatricians, psychologists, and
occupational therapists - each of whom had a minimum
of 5 years experience working with children in paediatric
or child mental health settings. Each of them was asked
to rate the importance and relevance of the various do-
mains for the purpose of the PONS. There was 100 per-
cent agreement regarding the merits of inclusion of the
domain in the draft version of the PONS and a consen-
sus reached about its relevance. Redundant or overlap-
ping symptom domains were removed. The second draft
of the PONS scale was then presented to young people
(aged 5 to 18 years), and their parents for feedback, and
to obtain information about comprehensibility and ap-
propriateness of both the content and format of the
questions. Focus groups for young people and their
parents were conducted separately to understand their
different perspectives. The mean duration of these focus
groups was 90 min for young people and their parents.
The major topics evaluated in the focus groups were
structure (e.g., format of the questions, response options),
content (e.g., meaning of each symptom domain, lan-
guage used to describe it), and other aspects such as fre-
quency of administration and recall period. Finally, a
discussion between experts in child and adolescent
neuropsychiatry and paediatric neurodisability was held
based on the summary reports by the focus groups and
the final version of the PONS scale was developed for
young people and parents, as well as for clinicians. It
was ensured that the PONS covered child or parent
rated symptoms of neurodevelopmental disorders such
as attention deficit hyperactivity disorder and autism
spectrum disorders, alongside symptoms of psychoses,
bipolar disorder, anxiety and depression. The final PONS
scale (parent version) consisted of 30 domains with re-
sponse options on a 7-point Likert scale because develop-
mentally up to 7-point options can be easily distinguished
by adults [26, 27] and feedback from focus groups sug-
gested it to be best option for the PONS. Also, having
7-point Likert scale allows a greater likelihood of being
able to capture subtle change accurately across time. The
PONS scales are incorporated into the HealthTracker™
platform [21] and are used in different clinical and research
settings. Currently, the HealthTracker™ system is used in
two EU FP7 projects - the Suicidality: Treatment Occur-
ring in Paediatrics (STOP study; www.stop-study.com) [22]
and the Managing the Link and Strengthening Transition
from Child to Adult Mental Health Care (MILESTONE)
project (www.milestone-transitionstudy.eu).
Phase 2: psychometric evaluation of the PONS scale
Subjects and procedures
After Institutional Review Board approval we used two
samples in order to examine the psychometric properties
of the PONS scale: a) a convenience sample of 929 children
and adolescents from the general population (466 boys and
463 girls); children (5–12 years old; mean age 10.1 years,
SD = 3.99) and adolescents (12–18 years old; mean age
13.9 years, SD = 3.65). Professional online marketing re-
sources helped identify ideal user groups to target (such as
parenting websites). Online guidance was clear that our
target audience was parents of primary and secondary
school children without a previous history of behavioural
and emotional problems, or involvement with child mental
health services.
b) 147 children and adolescents (109 boys, 38 girls),
aged 5 to 18 years (mean = 11.09, SD = 3.2) with neu-
ropsychiatric disorders, recruited from the Centre for
Interventional Paediatric Psychopharmacology (CIPP) at
the Maudsley Hospital, London. Parents were interviewed
at intake about the neuropsychiatric symptoms of their
children using the PONS (parent version). In addition, for
the neuropsychiatric condition sample, children and par-
ents were also interviewed for the presence of current and
lifetime psychiatric disorders and completed the Develop-
ment and Well-Being Assessment (DAWBA) [7].
The data capture, storage, and e-monitoring was con-
ducted online using the HealthTracker™ system. Health-
Tracker™ is an established health-monitoring platform
for online collection, storage of medical data, and data-
export to an SPSS database.
Statistical analyses
SPSS version 20.0 was used for the analyses. Descriptive
statistics was used to characterize both samples. Relia-
bility was assessed using Cronbach’s alpha, alpha if de-
leted analysis, intra-class correlation, and factor analysis
using the general population. Exploratory factor analysis
with Promax rotation and Kaiser normalization was
done with rotation converged in 10 interactions. Prin-
cipal axis factoring without fixed number of factors was
used. Promax rotation was used with a maximum inter-
action for convergence of 0.25 (Kappa = 4). A priori
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threshold to determine the loading of factors was set.
Given the explorative purpose of the present study and
our sample size we set the factors’ loading threshold
at >0.25 [28–33]. Only the greater value was considered
when cross-loadings presented a gap >0.2 between the
loadings. In addition, Kaiser-Meyer-Olikin (KMO) mea-
sure of sampling adequacy and Bartlett’s test of sphe-
ricity was provided.
Validity was assessed using the receiver operating
characteristic (ROC) analyses. This was computed to
evaluate the discriminative power of the factors between
both samples. This has been detailed in Additional file 1
(details available in the Results section). In addition, in-
dependent samples t-tests were performed with grou-
ping variable DAWBA diagnoses (coded in 1 for positive
and 0 for negative diagnosis) and single factor’s scores as
dependent variables to assess the PONS ability to distin-
guish between different groups of patients and to classify
them on the basis of DAWBA diagnosis.
PONS’ cut off scores, sensitivity, and specificity was
also computed. All p-values are for two-tailed tests with
α = 0.05.
Results
Phase 1: qualitative development of the PONS scale
Parents specifically supported the strategy of the PONS
consisting of domains that describe specific areas of dys-
function and believed that the traditional approach of
having many separate items for each domain would lead
to a longer scale and reduce uptake. The final PONS
scale (parent) consisted of 30 symptom domains. Each
domain includes its name domain, its description, and
two questions, one about the frequency and the other
one about impairment. The HealthTracker™ system en-
sures that the impairment question only appears if the
frequency question is answered as being present, thus
speeding up completions. This feature was strongly sup-
ported by all the users during the focus groups. All
symptom domains are rated on a 7-point scale and the
recall period was 1 month for baseline administration.
Phase 2: psychometric evaluation of the PONS scale
Subjects
The sample with neuropsychiatric conditions consisted
of 147 children and adolescents with various psychiatric
disorders, some of who had multiple comorbid disor-
ders. 75.5 % had Attention Deficit Hyperactivity Dis-
order (ADHD) (n = 111), 65.3 % had Autism Spectrum
Disorder (ASD) (n = 96), 40.1 % had Oppositional Defiant
Disorder (ODD) or Conduct Disorder (n = 59), 21.1 %
had psychoses or Bipolar Disorder (BP) (n = 31), 54.4 %
had Anxiety or Depressive Disorder (n = 80), 25.9 % had
Developmental Coordination Disorder (n = 38), and




As shown in Table 1, factor analysis was completed on the
30 symptom domains. A 4-factor model was determined to
best fit the data based on the screen plot. Based on the pat-
tern of symptom domain loading, the 4-factors were
named: (1) Neurodevelopmental Disability (predominantly
ADHD, ASD), (2) Behavioural and Emotional Dysregula-
tion (ODD, CD), (3) Psychoses and Personality Dysfunc-
tion (Psychoses, BP, emerging PD, spontaneous abnormal
movements [34]), (4) Anxiety and Depression (Anxiety and
Depressive Disorders). These factors capture the bulk of
children and adolescents with mental health problems and
intuitively follow clinical and diagnostic clusters.
The KMO was 0.97 (X2 = 20,507, 54) with a Bartlett’s
test of sphericity of 378, p ≤ 0.001.
Internal consistency
Cronbach’s alpha was 0.96 for the 30 PONS symptom
domains (referred to as items here). There were no
negative inter-item correlations and each item-total cor-
relations were above the threshold of >0.20. In addition,
the alpha if deleted analysis showed that the Cronbach’s
alpha value reduced if any of the PONS items were
dropped, meaning that there was no need to drop any
items.
Intra-class correlation
Intra-class correlation coefficient for single measures
was 0.44 (0.42-0.46 95 % CI, F = 22.84, p ≤ 0.001) and for
average measures was 0.96 (0.95-0.96 95 % CI, F = 22.84,
p ≤ 0.001).
Validity
Receiver Operating Characteristic (ROC) analysis
As shown in Table 2, the ROC area for the 4-factors was
0.96 (SE = 0.006; 0.95-0.97 95 % CI). Results of the ROC
analysis for each of the factors are showed in Table 2.
T-test analysis
The results showed that the Neurodevelopmental Disability
score was significantly higher for patients who presented
with an ASD and/or ADHD diagnoses (t[145] = 3.999,
p < .001). The ODD and/or CD patients had a statistically
significant difference in the Behavioural and Emotional
Dysregulation score (t[145] = 3.352, p = .001). Moreover, the
Psychoses and Personality Dysfunction score was signifi-
cantly greater for those individuals who had psychoses
and/or bipolar disturbance (t[145] = 2.384, p = .0022). Fi-
nally, patients with depression and/or anxiety had signifi-
cantly greater Anxiety and Depression score (t[145] = 3.045,
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p = .003). Taken together, these results suggest that the
PONS can be used as a guide for clinical categorization.
Discussion
The PONS scale (parent version) is a web-based PCOM
that consists of 30 symptom domains rated on a 7-point
scale for both frequency and impairment and takes
around 10 min to complete online. The PONS ensures
that child and parent rated symptoms of neurodevelop-
mental disorders such as attention deficit hyperactivity
disorder and autism spectrum disorders alongside symp-
toms of psychoses; bipolar disorder, emerging
personality disorders; anxiety and depression exist in a
single scale which is brief and easy to use. Results show
that the PONS scale is a reliable and valid instrument in
screening for psychiatric disorders in children and ado-
lescents with neuropsychiatric conditions.
Specifically, we found an internal consistency value
very close to 1.0 suggesting excellent reliability and pro-
viding evidence that the symptom domains measure a
common underlying construct. In addition, we found
medium correlation for individual symptom domains
and high correlations for the full instrument, suggesting
that each symptom domain is unique.




2 : Behaviour and
Emotional Dysregulation
3 : Psychoses and
Personality Dysfunction
4 : Anxiety and
Depression
Language problems .670 .066 .053 .049
Clumsiness .662 −.121 .111 .123
Difficulties learning .661 .003 −.058 .089
Social communication difficulties .617 .010 .041 .195
Inattention .614 .360 −.177 −.012
Mannerisms .566 −.070 .476 −.136
Impulsivity .548 .457 −.074 −.111
Hyperactivity .538 .351 .083 −.198
Cognitive rigidity .524 .163 −.045 .214
Sensory symptoms .501 −.185 .127 .298
Circumscribed interests .398 .046 .192 .127
Obsessions compulsions .385 −.069 .266 .241
Body control .348 .023 .286 −.191
Aggression −.035 .862 .018 .011
Oppositionality .098 .803 −.083 −.007
Explosive rage .010 .734 .026 .083
Lack remorse .157 .552 .076 .062
Labile mood .051 .533 .011 .271
Eating problems .166 .210 .037 .193
Hallucinations .023 −.116 .702 .058
Spontaneous abnormal movements .236 −.069 .668 −.133
SelfInjury .021 .129 .556 .081
Antisocial behaviour −.132 .423 .524 −.046
Paranoid thoughts −.060 .158 .375 .337
Manic symptoms .190 .129 .347 .117
Worries .177 .032 −.129 .709
Low mood −.048 .150 .004 .685
Fears .291 −.089 −.051 .589
Depressive thoughts −.223 .239 .317 .505
Sleep problems .255 .174 −.043 .285
Extract Method: Principal Axis Factoring. Rotation Method: Promax with Kaiser Normalization. Rotation converged in 10 interactions
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The PONS factor structure matches the domain
framework of the PROMIS (www.nihpromis.org). The
4 PONS factors, (1) Neurodevelopmental Disability,
(2) Behavioural and Emotional Dysregulation (3) Psychoses
and Personality Dysfunction, and (4) Anxiety and Depres-
sion align to an extent to the PROMIS Peer Relationship
domain, the PROMIS Anger domain, and the PROMIS
Paediatric Anxiety and Depression domains. The PROMIS
currently does not have an equivalent for Psychoses and
Personality Dysfunction in children and does not capture
all symptoms (www.nihpromis.org). The PONS uniquely
captures symptoms of developmental disorders such as
ADHD, Autism Spectrum Disorder, Obsessive Compulsive
Disorder, motor coordination disorder, disruptive disorders
such as ODD and Conduct Disorder; Psychoses, Bipolar
Disorder, and Emerging Personality Disorder; and Depres-
sion and Anxiety Disorders. Currently no existing single
scale is able to capture all these symptoms in around
10 min. Whilst the Strengths and Difficulties Question-
naires (SDQ) [7], is a brief, valid and widely used question-
naire, it does not cover psychoses, personality dysfunction,
bipolar disorder, etc., and has not been used regularly to
capture change between clinic appointments. The Child
Behavior Checklist (CBCL) [6] is much longer, more time
consuming and is not a simple PCOM that can be com-
pleted in around 10 min and does not have the online
optimization available for the PONS using audio recor-
dings or animations for the child versions of the PONS.
The PONS is unique in that this is an instrument that has
been clearly validated for web-based use. The capture of
domain-specific, dimensional frequency and impairment
ratings, uniquely allows the PONS to be used across diag-
nostic categories, allowing for use in research using the
NIH Research Domain Criteria (RDoC) [8]. Most impor-
tantly, the parents were very pleased with the format of the
PONS and it is a PCOM that has been developed with the
full input of the users.
Optimized, web-based PCOMs using intelligent bran-
ching, audio-assistance for those with reading difficulties,
adaptations for visual impairment (with large font-size ad-
aptations), availability in multiple languages increases the
likelihood of the PCOM being used. All these have been
specifically achieved with the PONS on the HealthTracker™.
It is likely to increase the use and completions of ques-
tionnaires, improve access to care in geographically iso-
lated populations, could be used for automated triaging,
and automated, real-time scoring allows for the results to
be available for use by clinicians during clinic visits, even
if the PONS was completed in the waiting area whilst
waiting to see the clinician.
Feedback from parents was very positive from the focus
group. Intelligent branching through online delivery from
the HealthTracker™ system minimises completion time
(maximum 12 min). The HealthTracker™ system also
automatically randomises the order of the symptom do-
mains being presented, and thus significantly reduces
practice effects.
The HealthTracker™ system has been specifically tested
for user acceptance and optimised for the use of children,
adolescents and parents, allowing them to complete it ef-
fortlessly. The scale also can be read by a recorded voice,
which is especially helpful when it comes to those with
dyslexia. In addition, the allocation of the versions of the
PONS is automatically assigned based on developmental
age, rather than chronological age, which is of utmost im-
portance for those with neurodisability.
Furthermore, the HealthTracker™ system allows the
PONS to be used for neuropsychiatric screening of chil-
dren and adolescents and automated triaging in busy
clinics. Clinically, the HealthTracker™ platform allows the
PONS scores to be automatically calculated and presented
in a graphical manner. This real-time shared feedback
allows optimal use of face-to-face and non face-to-face
clinical time.
The potential limitations of this study include that
PONS was primarily developed as a screening measure
and to assist in triaging. We have subsequently used the
instrument in epidemiological studies and tested its use-
fulness against other measures. As this instrument is for
online use, it was important that normative data be ac-
quired online. This means, however, that we were not
able to practically supervise every online entry, and
Table 2 Receiver operating characteristics of the factor analyses using the Profile of Neuropsychiatric Symptoms (PONS) between








(%) (%) (95 % CI)
Total ≥77.50 91.80 90.10 .960 .006 .950 .971
Neurodevelopmental Disability ≥37.50 91.80 91.10 .961 .006 .949 .973
Behaviour and Emotional Dysregulation ≥19.50 87.10 87.40 .936 .009 .918 .954
Psychoses and Personality Dysfunction ≥4.54 84.40 83.30 .901 .014 .873 .929
Anxiety and Depression ≥11.68 83.00 82.50 .909 .011 .887 .931
ROC: Receiver Operating Characteristics; SE: Standard Error; CI: Confidential Interval
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cannot be entirely sure that completions for the norma-
tive sample were by parents with children that had no
psychiatric problems. We believe that the large numbers
recruited means that such errors will be small, and
the advantages of test administration in its intended en-
vironment outweigh any disadvantages. In addition, the
clinical sample is modest in size and comes from a na-
tional specialist child and adolescent mental health ser-
vice (CAMHS) setting and may not be representative of
symptom profiles in less severely ill subjects seen in
community CAMHS.
However, this neuropsychiatric sample shows that the
PONS screened and identified psychiatric conditions
with excellent reliability. There is a need to test diagnos-
tic accuracy of the empirically derived PONS diagnoses
in children and adolescents in community child and
adolescent mental health and neurodisability services
and to assess triaging utility. Future longitudinal studies
will report the ability of the PONS to capture change in
symptom severity and impairment.
Conclusion
In summary, the PONS scale (parent version) is a Health-
Tracker™ system-based fast, engaging PCOM with excel-
lent psychometric properties that reports on the frequency
and impairment produced by neuropsychiatric symptoms
and neurodisability. The PONS-parent version consists of
30 symptom domains, rated on a 7-point scale for fre-
quency and impairment, covers a comprehensive variety of
psychopathology - ADHD, ASD, ODD, OCD, Anxiety,
Depression, Psychoses and Bipolar Disorder and is espe-
cially appropriate for use in those with neurodisabilities. It
allows clinicians to profile children and adolescents with
emotional and behavioural problems, and could be useful
in clinical screening and triaging, and can also be used in
clinical trials and epidemiological research. As it is available
online with automated scoring and immediate feedback of
statistically significant cut-off points, it assists clinicians
with diagnostic decision making and optimises use of clin-
ician time. Future research will need to examine PONS as a
change measure.
Additional file
Additional file 1: ROC Curves. ROC Curves for the factor scores and
total score of the PONS scale. In the plots, the horizontal axis is the
specificity and the vertical axis is the sensitivity.
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